Diastolic heart failure is defined clinically when signs and symptoms of heart failure are present in the presence of preserved left ventricular systolic function (ejection fraction >45%).

Postmarket data on MitraClip lend further support to the idea that this subgroup fares as well as the overall SMR population.

Mavacamten had been FDA approved on the basis of the EXPLORER-HCM trial's finding that the drug resulted in better functional ...

It should be appreciated that clinical heart failure with preserved systolic function (diastolic heart failure) can be caused by heterogeneous pathophysiologic conditions. Hypertrophic ...

A new study found that blocking the activity of the blood sugar regulating hormone, glucagon, improves heart function in ...

Australian research has found a link between snoring and elevated blood pressure According to the study which was conducted by sleep scientists from ...

Images from electrocardiogram (ECG) tests to show heart function. Those with heart failure with preserved ejection fraction (HFpEF), in the middle column, have worse heart diastolic function. Those ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced encouraging topline results from its Phase 2b SEISMiC Extension ...

Blood pressure plays a pivotal role in the intricate machinery of the human body, as it is the force exerted by circulating ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

GlobalData’s report assesses the drugs in the Collagenase 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

A calcium transient measurement system utilizing human induced pluripotent stem cell-derived cardiomyocytes reveals the detrimental impact of inflammatory cytokines on cardiomyocyte relaxation and ...